Exelixis Inc (EXEL.OQ)

EXEL.OQ on NASDAQ Stock Exchange Global Select Market

3.33USD
11 Jul 2014
Price Change (% chg)

$0.08 (+2.31%)
Prev Close
$3.25
Open
$3.25
Day's High
$3.39
Day's Low
$3.25
Volume
334,859
Avg. Vol
699,496
52-wk High
$8.41
52-wk Low
$3.02

EXEL.OQ

Chart for EXEL.OQ

About

Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds. Cabozantinib is the inhibitor of MET in clinical development and is... (more)

Overall

Beta: 2.40
Market Cap (Mil.): $647.36
Shares Outstanding (Mil.): 194.69
Dividend: --
Yield (%): --

Financials

  EXEL.OQ Industry Sector
P/E (TTM): -- 102.68 35.77
EPS (TTM): -1.48 -- --
ROI: -53.95 -0.70 18.27
ROE: -168.32 -1.57 19.16
Search Stocks

Competitors

  Price Change
AstraZeneca plc (AZN.L) 4,353.50p +8.50
Pfizer Inc. (PFE.N) $30.07 +0.07
ArQule, Inc. (ARQL.OQ) $1.43 --
GlaxoSmithKline plc (GSK.L) 1,562.00p -10.00
Algeta ASA (ALGETA.OL) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks